PORT-9 | Interleukin Related interleukin-related.com

Product Name :
PORT-9

Search keywords :
TT3

drugId :
null

Target Vo:
Adenosine A2b receptor

Target Vo Short Name :
ADORA2B

Moa_Name:
Adenosine A2b receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Tarus Therapeutics Inc

Active Company_Name :
Tarus Therapeutics Inc

Active Indication_Name:
Colorectal Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NF-KB p105 Antibody (YA700)
Ki-67 Antibody
NLRP3 Antibody: NLRP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 118 kDa, targeting to NLRP3. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Mouse, Rat.

Author: Interleukin Related

Related Posts